Vol 11, N°3 Neurotoxicity and Neuroprotection
Past issues Contributors How to publish Contributions and comments Home
 
C o n t e n t s Editorial Jean-Paul Macher In this issue David R. Rubinow State of the art Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression    Ronald S. Duman (USA) Translational research Chromatin regulation in drug addiction and depression William Renthal, Eric J. Nestler (USA) Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia David A. Lewis (USA) The role of astroglia in neuroprotection Mireille Bélanger, Pierre J. Magistretti (Switzerland) Estradiol: a hormone with diverse and contradictory neuroprotective actions Phyllis M. Wise, Shotaro Suzuki, Candice M. Brown (USA) Neurotoxicity of drugs of abuse—the case of methylenedioxyamphetamines MDMA, ecstasy), and stimulant amphetamines Euphrosyne Gouzoulis-Mayfrank, Joerg Daumann (Germany) Pharmacological aspects The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders—relation to drug treatment Norbert Müller, Aye-Mu Myint, Markus J. Schwarz (Germany) The neurotrophic and neuroprotective effects of psychotropic agents Joshua Hunsberger, Daniel R. Austin, Ioline D. Henter, Guang Chen (USA) Brief report Neuroplasticity in addictive disorders Charles P. O’Brien (USA) ISSUE COORDINATED BY: David R. Rubinow